He/him/his
National Institutes of Health, National Institute of General Medical Sciences
People: Ruoran Li, Katia Koelle, Jon Zelner, Ben Lopman, Andreas Handel, Kristin Nelson
2018 – 2024 Continue Reading Integrating data streams with multi-scale modeling to guide norovirus vaccine decision-making
Conyers SA, Deshpande A, Amin AB, Sivakumar R, McQuade ER, Lopman B. (2026). Identifying the optimal schedule for a multi-pathogen combination vaccine for diarrheal disease. Epidemics, (56)
Miller SL, Billings WZ, John M, Hemme H, Atmar RL, Bernstein DI, Shen Y, Winter AK, Koelle K, Lopman BA, Handel A. (2026). Evaluation of serum antibodies as correlates of protection against norovirus infection and disease. The Journal of infectious diseases
Doran C, Sheku M, Nakada Y, Lopman B, Nelson K. (2026). Relevance of social contact definitions for use in infectious disease transmission modeling: a systematic review and recommendations. BMC infectious diseases
Chen D, Shioda K, Brouwer AF, Kraay ANM, Handel A, Lopman BA, McQuade ETR, Nelson K. (2026). A Novel Transmission Model-based Method to Evaluate Population Attribution Methods for Norovirus and Rotavirus Diarrhea. Epidemiology (Cambridge, Mass.)
Nelson KN, Shiiba M, Srinivasan R, Brown TS, Martinez L, Doran C, Biswas S, Raghava V, Sacoor C, Kazi M, Maldonado H, Omer S, Lopman B. (2026). Characterizing social behavior relevant for tuberculosis transmission in four low- and middle-income countries. BMC infectious diseases
Shiiba M, Bruck M, Sesay MM, Hudgins AF, Segall MF, Prasad P, Doran CR, Siegler AJ, Lobelo F, Ryerson AB, Lopman B, Nelson KN, Ahmed SM. (2026). Estimating modern US social contact patterns, the ENGAGED study: a study protocol for a staggered longitudinal cohort study. BMJ open, 16(5)
Shen J, Kim C, Bush C, Wu WH, Bridges C, Olmsted AE, Baker JM, Patterson BJ, Lopman BA, Payne DC, Anderson EJ, Carlson KB. (2026). Individual-level Factors Associated With Acute Hospitalization After Medically Attended Acute Gastroenteritis and Norovirus Gastroenteritis in the United States, 2022-2024. Open forum infectious diseases, 13(7)
Pischel L, Aguolu OG, Ahmed N, Campbell MM, Borg R, Duckwall C, Willebrand K, Zaleski A, Paintsil EE, Muenker MC, Malik AA, Kiti MC, Warren JL, Jenness SM, Lopman BA, Belsky J, Martinello RA, Yildirim I, Ko AI, Omer SB. (2025). Social mixing patterns of United States healthcare personnel at a quaternary health center: a prospective observational study. Infection control and hospital epidemiology
Wallrafen-Sam K, Quesada MG, Lopman BA, Jenness SM. (2025). Modelling the interplay between responsive individual vaccination decisions and the spread of SARS-CoV-2. Epidemics, (51)
Koelle K, Lappe B, Lopman BA, Lau MSY, Viscidi E, Carlson KB. (2025). Projecting the population-level impact of norovirus vaccines. Epidemics, (52)
Amin AB, Garcia Quesada M, Liu J, Sivakumar R, Conyers S, Lopman BA, Houpt E, Platts-Mills JA, Rogawski McQuade E. (2025). Natural history parameters for enteric pathogens to inform modeling studies of diarrhea among children in low-resource settings: results from the MAL-ED longitudinal birth cohort. BMC infectious diseases
Prunas O, Asare EO, Sajewski E, Li Y, Pithawala Z, Weinberger DM, Warren JL, Armah GE, Cunliffe NA, Iturriza-Gómara M, Lopman BA, Pitzer VE. (2025). Global estimates of rotavirus vaccine efficacy and effectiveness: a rapid review and meta-regression analysis. EClinicalMedicine, (81)
Carlson KB, Dilley A, O'Grady T, Johnson JA, Lopman B, Viscidi E. (2024). A narrative review of norovirus epidemiology, biology, and challenges to vaccine development. NPJ vaccines, 9(1)
Pitzer VE, Ndeketa L, Asare EO, Hungerford D, Lopman BA, Jere KC, Cunliffe NA. (2024). Impact of rotavirus vaccination in Malawi from 2012 to 2022 compared to model predictions. NPJ vaccines, 9(1)
Hartner AM, Li X, Echeverria-Londono S, Roth J, Abbas K, Auzenbergs M, de Villiers MJ, Ferrari MJ, Fraser K, Fu H, Hallett T, Hinsley W, Jit M, Karachaliou A, Moore SM, Nayagam S, Papadopoulos T, Perkins TA, Portnoy A, Minh QT, Vynnycky E, Winter AK, Burrows H, Chen C, Clapham HE, Deshpande A, Hauryski S, Huber J, Jean K, Kim C, Kim JH, Koh J, Lopman BA, Pitzer VE, Tam Y, Lambach P, Sim SY, Woodruff K, Ferguson NM, Trotter CL, Gaythorpe KAM. (2024). Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020-30: a modelling study. The Lancet. Global health, 12(4)
Keane A, Tippett A, Taylor EG, Reese O, Salazar L, De Castro K, Choi C, Ciric C, Taylor M, Mitchell A, Gibson T, Puzniak L, Hubler R, Valluri SR, Wiemken TL, Lopman BA, Kamidani S, Anderson LJ, McLaughlin JM, Rostad CA, Anderson EJ. (2024). Effectiveness of BNT162b2 Vaccine for Preventing COVID-19-Related Hospitalizations: A Test-Negative Case-Control Study. Vaccines, 12(6)
Kim SS, Garcia Quesada M, Prasad PV, Nelson KN, Lopman BA, Rogawski McQuade ET. (2024). Challenges of using the test-negative design to measure vaccine effectiveness of multi-pathogen combination vaccines targeting one syndrome. Vaccine
Asare EO, Al-Mamun MA, Armah GE, Lopman BA, Pitzer VE. (2024). Impact of dosing schedules on performance of rotavirus vaccines in Ghana. Science advances, 10(50)
Lappe BL, Wikswo ME, Kambhampati AK, Mirza SA, Tate JE, Kraay ANM, Lopman BA. (2023). Predicting norovirus and rotavirus resurgence in the United States following the COVID-19 pandemic: a mathematical modelling study. BMC infectious diseases, 23(1)
Cooper DK, Sobolik JS, Kovacevic J, Rock CM, Sajewski ET, Guest JL, Lopman BA, Jaykus LA, Leon JS. (2023). Combined Infection Control Interventions Protect Essential Food Workers from Occupational Exposures to SARS-CoV-2 in the Agricultural Environment. Applied and environmental microbiology, 89(7)
Kiti MC, Aguolu OG, Zelaya A, Chen HY, Ahmed N, Batross J, Liu CY, Nelson KN, Jenness SM, Melegaro A, Ahmed F, Malik F, Omer SB, Lopman BA. (2023). Changing social contact patterns among US workers during the COVID-19 pandemic: April 2020 to December 2021. Epidemics, (45)
Sanchez T, Hall E, Siegler AJ, Prakash-Asrani R, Bradley H, Fahimi M, Lopman B, Luisi N, Nelson KN, Sailey C, Shioda K, Valentine-Graves M, Sullivan PS. (2023). Prevalence of COVID-19 Mitigation Behaviors in US Adults (August-December 2020): Nationwide Household Probability Survey. JMIR public health and surveillance, (9)
Armah G, Lopman BA, Vinjé J, O'Ryan M, Lanata CF, Groome M, Ovitt J, Marshall C, Sajewski E, Riddle MS. (2023). Vaccine value profile for norovirus. Vaccine, (41 Suppl 2)
Cates J, Cardemil CV, Mirza SA, Lopman B, Hall AJ, Holodniy M, Lucero-Obusan C. (2023). Risk of Hospitalization and Mortality Following Medically Attended Norovirus Infection-Veterans Health Administration, 2010-2018. Open forum infectious diseases, 10(11)
Hall EW, Tippett A, Fridkin S, Anderson EJ, Lopman B, Benkeser D, Baker JM. (2022). Association Between Rotavirus Vaccination and Antibiotic Prescribing Among Commercially Insured US Children, 2007-2018. Open forum infectious diseases, 9(7)
Amin AB, Tate JE, Waller LA, Lash TL, Lopman BA. (2022). Monovalent rotavirus vaccine efficacy against different rotavirus genotypes: a pooled analysis of Phase II and III trial data. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Sobolik JS, Sajewski ET, Jaykus LA, Cooper DK, Lopman BA, Kraay ANM, Ryan PB, Guest JL, Webb-Girard A, Leon JS. (2022). Decontamination of SARS-CoV-2 from cold-chain food packaging provides no marginal benefit in risk reduction to food workers. Food control
Amin AB, Lash TL, Tate JE, Waller LA, Wikswo ME, Parashar UD, Stewart LS, Chappell JD, Halasa NB, Williams JV, Michaels MG, Hickey RW, Klein EJ, Englund JA, Weinberg GA, Szilagyi PG, Staat MA, McNeal MM, Boom JA, Sahni LC, Selvarangan R, Harrison CJ, Moffatt ME, Schuster JE, Pahud BA, Weddle GM, Azimi PH, Johnston SH, Payne DC, Bowen MD, Lopman BA. (2022). Understanding Variation in Rotavirus Vaccine Effectiveness Estimates in the United States: The Role of Rotavirus Activity and Diagnostic Misclassification. Epidemiology (Cambridge, Mass.)
Asare EO, Hergott D, Seiler J, Morgan B, Archer H, Wiyeh AB, Guo B, Driver M, Giersing B, Hasso-Agopsowicz M, Lingappa J, Lopman BA, Pitzer VE. (2022). Case fatality risk of diarrhoeal pathogens: a systematic review and meta-analysis. International journal of epidemiology
Koelle K, Martin MA, Antia R, Lopman B, Dean NE. (2022). The changing epidemiology of SARS-CoV-2. Science (New York, N.Y.), 375(6585)
Hall EW, Weng MK, Harris AM, Schillie S, Nelson NP, Ortega-Sanchez IR, Rosenthal E, Sullivan PS, Lopman B, Jones J, Bradley H, Rosenberg ES. (2022). Assessing the cost-utility of universal hepatitis B vaccination among adults. The Journal of infectious diseases
Shioda K, Lopman B. (2022). How to interpret the total number of SARS-CoV-2 infections. Lancet
Nelson K, Lopman B. (2022). The hiatus of the handshake. Science (New York, N.Y.), 377(6601)
Cates JE, Amin AB, Tate JE, Lopman B, Parashar U. (2021). Do Rotavirus Strains Affect Vaccine Effectiveness? A Systematic Review and Meta-analysis. The Pediatric infectious disease journal, 40(12)
Glover-Addy H, Ansong D, Enweronu-Laryea C, Tate JE, Amponsa-Achiano K, Sarkodie B, Mwenda JM, Diamenu S, Owusu SK, Nimako B, Mensah NK, Armachie J, Narh C, Pringle K, Grytdal SP, Binka F, Lopman B, Parashar UD, Armah G. (2021). Epidemiology of intussusception in infants less than one year of age in Ghana, 2012-2016. The Pan African medical journal, 39(Suppl 1)
Sobolik JS, Sajewski ET, Jaykus LA, Cooper DK, Lopman BA, Kraay AN, Ryan PB, Guest JL, Webb-Girard A, Leon JS. (2021). Low risk of SARS-CoV-2 transmission via fomite, even in cold-chain. medRxiv : the preprint server for health sciences
Kraay ANM, Hayashi MAL, Berendes DM, Sobolik JS, Leon JS, Lopman BA. (2021). Risk for Fomite-Mediated Transmission of SARS-CoV-2 in Child Daycares, Schools, Nursing Homes, and Offices. Emerging infectious diseases, 27(4)
Sobolik JS, Sajewski ET, Jaykus LA, Cooper DK, Lopman BA, Kraay ANM, Ryan PB, Leon JS. (2021). Controlling risk of SARS-CoV-2 infection in essential workers of enclosed food manufacturing facilities. Food control
Hall EW, Bradley HM, Jones J, Rosenberg ES, Lopman B, Sullivan PS. (2021). Describing the changing relationship between opioid prescribing rates and overdose mortality: A novel county-level metric. Drug and alcohol dependence, (225)
Hall EW, Schillie S, Vaughan AS, Jones J, Bradley H, Lopman B, Rosenberg E, Sullivan P. (2021). County-Level Variation in Hepatitis C Virus Mortality and Trends in the United States, 2005-2017. Hepatology (Baltimore, Md.)
Yildirim I, Kao CM, Tippett A, Suntarattiwong P, Munye M, Yi J, Elmontser M, Quincer E, Focht C, Watson N, Bilen H, Baker JM, Lopman B, Hogenesch E, Rostad CA, Anderson EJ. (2021). A Retrospective Test-Negative Case-Control Study to Evaluate Influenza Vaccine Effectiveness in Preventing Hospitalizations in Children. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Chamberlain AT, Toomey KE, Bradley H, Hall EW, Fahimi M, Lopman BA, Luisi N, Sanchez T, Drenzek C, Shioda K, Siegler AJ, Sullivan PS. (2021). Cumulative incidence of SARS-CoV-2 infections among adults in Georgia, USA, August-December 2020. The Journal of infectious diseases
Baker JM, Hasso-Agopsowicz M, Pitzer VE, Platts-Mills JA, Peralta-Santos A, Troja C, Archer H, Guo B, Sheahan W, Lingappa J, Jit M, Lopman BA. (2021). Association of enteropathogen detection with diarrhoea by age and high versus low child mortality settings: a systematic review and meta-analysis. The Lancet. Global health, 9(10)
Kiti MC, Aguolu OG, Liu CY, Mesa AR, Regina R, Woody M, Willebrand K, Couzens C, Bartelsmeyer T, Nelson KN, Jenness S, Riley S, Melegaro A, Ahmed F, Malik F, Lopman BA, Omer SB. (2021). Social contact patterns among employees in 3 U.S. companies during early phases of the COVID-19 pandemic, April to June 2020. Epidemics, (36)
Lopman B, Liu CY, Le Guillou A, Handel A, Lash TL, Isakov AP, Jenness SM. (2021). A modeling study to inform screening and testing interventions for the control of SARS-CoV-2 on university campuses. Scientific reports, 11(1)
Carol Y. Liu, Juliette Berlin, Moses C. Kiti, Emanuele Del Fava, André Grow, Emilio Zagheni, Alessia Melegaro, Samuel M. Jenness, Saad Omer, Benjamin Lopman, Kristin Nelson. (2021). Rapid review of social contact patterns during the COVID-19 pandemic. medRxiv
Liu CY, Berlin J, Kiti MC, Del Fava E, Grow A, Zagheni E, Melegaro A, Jenness SM, Omer SB, Lopman B, Nelson K. (2021). Rapid review of social contact patterns during the COVID-19 pandemic. Epidemiology (Cambridge, Mass.)
Kraay ANM, Nelson KN, Zhao CY, Demory D, Weitz JS, Lopman BA. (2021). Modeling serological testing to inform relaxation of social distancing for COVID-19 control. Nature communications, 12(1)
Shioda K, Lau MS, Kraay AN, Nelson KN, Siegler AJ, Sullivan PS, Collins MH, Weitz JS, Lopman BA. (2021). Estimating the cumulative incidence of SARS-CoV-2 infection and the infection fatality ratio in light of waning antibodies. Epidemiology (Cambridge, Mass.)
Jenness SM, Willebrand KS, Malik AA, Lopman BA, Omer SB. (2020). Modeling Dynamic Network Strategies for SARS-CoV-2 Control on a Cruise Ship. medRxiv : the preprint server for health sciences
Gallagher ME, Sieben AJ, Nelson KN, Kraay ANM, Orenstein WA, Lopman B, Handel A, Koelle K. (2020). Indirect benefits are a crucial consideration when evaluating SARS-CoV-2 vaccine candidates. Nature medicine
Lau MSY, Grenfell B, Thomas M, Bryan M, Nelson K, Lopman B. (2020). Characterizing superspreading events and age-specific infectiousness of SARS-CoV-2 transmission in Georgia, USA. Proceedings of the National Academy of Sciences of the United States of America, 117(36)
Steele MK, Wikswo ME, Hall AJ, Koelle K, Handel A, Levy K, Waller LA, Lopman BA. (2020). Characterizing Norovirus Transmission from Outbreak Data, United States. Emerging infectious diseases, 26(8)
Bradley H, Fahimi M, Sanchez T, Lopman B, Frankel M, Kelley CF, Rothenberg R, Siegler AJ, Sullivan PS. (2020). [WITHDRAWN] Early Release Estimates for SARS-CoV-2 Prevalence and Antibody Response Interim Weighting for Probability-Based Sample Surveys. medRxiv : the preprint server for health sciences
Moses C. Kiti, Obianuju G. Aguolu, Carol Y. Liu, Ana R. Mesa, Rachel Regina, Kathryn Willebrand, Chandra Couzens, Tilman Bartelsmeyer, Kristin Nelson, Samuel Jenness, Steven Riley, Alessia Melegaro, Faruque Ahmed, Fauzia Malik, Ben Lopman, Saad B. Omer. (2020). Social contact patterns among employees in 3 U.S. companies during early phases of the COVID-19 pandemic, April to June 2020. medRxiv
Baker JM, Tate JE, Leon J, Haber MJ, Pitzer VE, Lopman BA. (2020). Post-vaccination serum anti-rotavirus immunoglobulin A as a correlate of protection against rotavirus gastroenteritis across settings. The Journal of infectious diseases
Ai CE, Steele M, Lopman B. (2020). Disease burden and seasonal impact of improving rotavirus vaccine coverage in the United States: A modeling study. PloS one, 15(2)
Gallagher ME, Sieben AJ, Nelson KN, Kraay ANM, Lopman B, Handel A, Koelle K. (2020). Considering indirect benefits is critical when evaluating SARS-CoV-2 vaccine candidates. medRxiv : the preprint server for health sciences
Siegler AJ, Sullivan PS, Sanchez T, Lopman B, Fahimi M, Sailey C, Frankel M, Rothenberg R, Kelley CF, Bradley H. (2020). Protocol for a national probability survey using home specimen collection methods to assess prevalence and incidence of SARS-CoV-2 infection and antibody response. Annals of epidemiology
Asare EO, Al-Mamun MA, Armah GE, Lopman BA, Parashar UD, Binka F, Pitzer VE. (2020). Modeling of rotavirus transmission dynamics and impact of vaccination in Ghana. Vaccine, 38(31)
Arrouzet CJ, Ellis K, Kambhampati A, Chen Y, Steele M, Lopman B. (2020). Population-level human secretor status is associated with genogroup 2 type 4 norovirus predominance. The Journal of infectious diseases
Baker JM, Nelson KN, Overton E, Lopman BA, Lash TL, Photakis M, Jacob JT, Roback J, Fridkin SK, Steinberg JP. (2020). Quantification of occupational and community risk factors for SARS-CoV-2 seropositivity among healthcare workers in a large U.S. healthcare system. medRxiv : the preprint server for health sciences
Nelson KN, Gandhi NR, Mathema B, Lopman BA, Brust JCM, Auld SC, Ismail N, Omar SV, Brown TS, Allana S, Campbell A, Moodley P, Mlisana K, Shah NS, Jenness SM. (2020). Modeling Missing Cases and Transmission Links in Networks of Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa. American journal of epidemiology
Olson DR, Lopman BA, Konty KJ, Mathes RW, Papadouka V, Ternier A, Zucker JR, Simonsen L, Grenfell BT, Pitzer VE. (2020). Surveillance data confirm multiyear predictions of rotavirus dynamics in New York City. Science advances, 6(9)
Lopman B, Hall A. (2019). Incomplete use of global data for aetiological attribution of diarrhoeal disease in the Global Burden of Disease study. The Lancet. Infectious diseases, 19(2)
Lewnard JA, Lopman BA, Parashar UD, Bennett A, Bar-Zeev N, Cunliffe NA, Samuel P, Guerrero ML, Ruiz-Palacios G, Kang G, Pitzer VE. (2019). Heterogeneous susceptibility to rotavirus infection and gastroenteritis in two birth cohort studies: Parameter estimation and epidemiological implications. PLoS computational biology, 15(7)
Derek J. Williams, Kathryn M. Edwards, Daniel C. Payne, Judith Manning, Umesh D. Parashar and Benjamin A. Lopman. (2019). Decline in gastroenteritis-related triage calls after rotavirus vaccine licensure. Pediatrics, 130(4)
Baker JM, Tate JE, Leon J, Haber MJ, Lopman BA. (2019). Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries. PLoS medicine, 16(12)
Grytdal S, Browne H, Collins N, Vargas B, Rodriguez-Barradas MC, Rimland D, Beenhouwer DO, Brown ST, Goetz MB, Lucero-Obusan C, Holodniy M, Kambhampati A, Parashar U, Vinjé J, Lopman B, Hall AJ, Cardemil CV. (2019). Trends in Incidence of Norovirus-associated Acute Gastroenteritis in 4 Veterans Affairs Medical Center Populations in the United States, 2011-2015. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 70(1)
Baker JM, Dahl RM, Cubilo J, Parashar UD, Lopman BA. (2019). Effects of the rotavirus vaccine program across age groups in the United States: analysis of national claims data, 2001-2016. BMC infectious diseases, 19(1)
Zelner J, Adams C, Havumaki J, Lopman B. (2019). Understanding the importance of contact heterogeneity and variable infectiousness in the dynamics of a large Norovirus outbreak. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Nelson KN, Jenness SM, Mathema B, Lopman BA, Auld SC, Shah NS, Brust JCM, Ismail N, Omar SV, Brown TS, Allana S, Campbell A, Moodley P, Mlisana K, Gandhi NR. (2019). Social mixing and clinical features linked with transmission in a network of extensively drug-resistant (XDR) tuberculosis cases in KwaZulu-Natal, South Africa. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Williams AM, Ladva CN, Leon JS, Lopman BA, Tangpricha V, Whitehead RD, Armitage AE, Wray K, Morovat A, Pasricha SR, Thurnham D, Tanumihardjo SA, Shahab-Ferdows S, Allen L, Flores-Ayala RC, Suchdev PS. (2019). Changes in micronutrient and inflammation serum biomarker concentrations after a norovirus human challenge. The American journal of clinical nutrition, 110(6)
Osuka H, Hall AJ, Wikswo ME, Baker JM, Lopman BA. (2018). Temporal Relationship Between Healthcare-Associated and Nonhealthcare-Associated Norovirus Outbreaks and Google Trends Data in the United States. Infection control and hospital epidemiology, 39(3)
Baker JM, Tate JE, Steiner CA, Haber MJ, Parashar UD, Lopman BA. (2019). Longer-term Direct and Indirect Effects of Infant Rotavirus Vaccination Across All Ages in the United States in 2000-2013: Analysis of a Large Hospital Discharge Data Set. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 68(6)
Lopman B, Dahl R, Shah M, Parashar UD. (2018). Timing of Birth as an Emergent Risk Factor for Rotavirus Hospitalization and Vaccine Performance in the Postvaccination Era in the United States. American journal of epidemiology, 187(8)
Yang W, Steele M, Lopman B, Leon JS, Hall AJ. (2018). The Population-Level Impacts of Excluding Norovirus-Infected Food Workers From the Workplace: A Mathematical Modeling Study. American journal of epidemiology, 188(1)
Lopman BA, Pitzer VE. (2018). Waxing Understanding of Waning Immunity. The Journal of infectious diseases, 217(6)
O'Ryan M, Riera-Montes M, Lopman B. (2017). Norovirus in Latin America: Systematic Review and Meta-analysis. The Pediatric infectious disease journal, 36(2)
Romero C, Tinoco YO, Loli S, Razuri H, Soto G, Silva M, Galvan P, Kambhampati A, Parashar UD, Kasper MR, Bausch DG, Simons MP, Lopman B. (2017). Incidence of norovirus-associated diarrhea and vomiting disease among children and adults in a community cohort in the Peruvian Amazon Basin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 65(5)
O'Ryan M, Lopman BA. (2017). Parenteral protein-based rotavirus vaccine. The Lancet. Infectious diseases, 17(8)
Kayoko Shioda, Leslie Barclay, Sylvia Becker-Dreps, Filemon Bucardo-Rivera, Philip J Cooper, Daniel C Payne, Jan Vinjé, Benjamin A Lopman. (2017). Can use of viral load improve norovirus clinical diagnosis and disease attribution?. Open Forum Infectious Diseases, 4(3)
Lopman BA, Steele D, Kirkwood CD, Parashar UD. (2016). The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control. PLoS medicine, 13(4)
Gheorghita S, Birca L, Donos A, Wasley A, Birca I, Cojocaru R, Melnick A, Ciobanu S, Mosina L, Cortese MM, Parashar UD, Lopman B. (2016). Impact of Rotavirus Vaccine Introduction and Vaccine Effectiveness in the Republic of Moldova. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (62 Suppl 2)
Armah G, Pringle K, Enweronu-Laryea CC, Ansong D, Mwenda JM, Diamenu SK, Narh C, Lartey B, Binka F, Grytdal S, Patel M, Parashar U, Lopman B. (2016). Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in Ghana. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (62 Suppl 2)
Head MG, Lopman BA. (2016). Norovirus in 2016-Emesis Aplenty but Clear Signs of Progress. The Journal of infectious diseases, (213 Suppl 1)
Kambhampati A, Payne DC, Costantini V, Lopman BA. (2015). Host Genetic Susceptibility to Enteric Viruses: A Systematic Review and Metaanalysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 62(1)
Grytdal SP, Rimland D, Shirley SH, Rodriguez-Barradas MC, Goetz MB, Brown ST, Lucero-Obusan C, Holodniy M, Graber C, Parashar U, Vinjé J, Lopman B. (2015). Incidence of Medically-Attended Norovirus-Associated Acute Gastroenteritis in Four Veteran's Affairs Medical Center Populations in the United States, 2011-2012. PLoS One, 10(5)
Gastañaduy PA, Vicuña Y, Salazar F, Broncano N, Gregoricus N, Vinjé J, Chico M, Parashar UD, Cooper PJ, Lopman B. (2015). Transmission of Norovirus Within Households in Quininde, Ecuador. The Pediatric infectious disease journal, 34(9)
Bellan SE, Pulliam JR, Pearson CA, Champredon D, Fox SJ, Skrip L, Galvani AP, Gambhir M, Lopman BA, Porco TC, Meyers LA, Dushoff J. (2015). Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis. The Lancet. Infectious diseases, 15(6)
Shioda K, Kambhampati A, Hall AJ, Lopman BA. (2015). Global age distribution of pediatric norovirus cases. Vaccine, 33(33)
Kambhampati A, Koopmans M, Lopman BA. (2015). Burden of norovirus in healthcare facilities and strategies for outbreak control. The Journal of hospital infection, 89(4)
O'Dea EB, Pepin KM, Lopman BA, Wilke CO. (2014). Fitting outbreak models to data from many small norovirus outbreaks. Epidemics, (6)
Lopman BA, Trivedi T, Vicuña Y, Costantini V, Collins N, Gregoricus N, Parashar U, Sandoval C, Broncano N, Vaca M, Chico ME, Vinjé J, Cooper PJ. (2015). Norovirus Infection and Disease in an Ecuadorian Birth Cohort: Association of Certain Norovirus Genotypes With Host FUT2 Secretor Status. The Journal of infectious diseases, 211(11)
Barclay L, Park GW, Vega E, Hall A, Parashar U, Vinjé J, Lopman B. (2014). Infection control for norovirus. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 20(8)
Payne DC, Parashar UD, Lopman BA. (2015). Developments in understanding acquired immunity and innate susceptibility to norovirus and rotavirus gastroenteritis in children. Current opinion in pediatrics, 27(1)
Iturriza-Gómara M, Lopman B. (2014). Norovirus in healthcare settings. Current opinion in infectious diseases, 27(5)
Premkumar PS, Parashar UD, Gastanaduy PA, McCracken JP, de Oliveira LH, Payne DC, Patel MM, Tate JE, Lopman BA. (2015). Reduced rotavirus vaccine effectiveness among children born during the rotavirus season: a pooled analysis of 5 case-control studies from the Americas. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 60(7)
Ahmed SM, Hall AJ, Robinson AE, Verhoef L, Premkumar P, Parashar UD, Koopmans M, Lopman BA. (2014). Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis. The Lancet. Infectious diseases, 14(8)
Gastañaduy PA, Curns AT, Parashar UD, Lopman BA. (2013). Gastroenteritis hospitalizations in older children and adults in the United States before and after implementation of infant rotavirus vaccination. JAMA, 310(8)
Zelner JL, Lopman BA, Hall AJ, Ballesteros S, Grenfell BT. (2013). Linking time-varying symptomatology and intensity of infectiousness to patterns of norovirus transmission. PloS one, 8(7)
Rha B, Burrer S, Park S, Trivedi T, Parashar UD, Lopman BA. (2013). Emergency department visit data for rapid detection and monitoring of norovirus activity, United States. Emerging infectious diseases, 19(8)
Simmons K, Gambhir M, Leon J, Lopman B. (2013). Duration of immunity to norovirus gastroenteritis. Emerging infectious diseases, 19(8)
Gastañaduy PA, Hall AJ, Curns AT, Parashar UD, Lopman BA. (2013). Burden of norovirus gastroenteritis in the ambulatory setting--United States, 2001-2009. The Journal of infectious diseases, 207(7)
Lopman B, Vicuña Y, Salazar F, Broncano N, Esona MD, Sandoval C, Gregoricus N, Bowen MD, Payne D, Vaca M, Chico M, Parashar U, Cooper PJ. (2013). Household transmission of rotavirus in a community with rotavirus vaccination in Quininde, Ecuador. PLoS One, 8(7)
Lopman B, Simmons K, Gambhir M, Vinjé J, Parashar U. (2014). Epidemiologic implications of asymptomatic reinfection: a mathematical modeling study of norovirus. American journal of epidemiology, 179(4)
Lopman B, Kang G. (2014). In praise of birth cohorts: norovirus infection, disease, and immunity. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 58(4)
Lopman B, Gastañaduy P, Park GW, Hall AJ, Parashar UD, Vinjé J. (2012). Environmental transmission of norovirus gastroenteritis. Current opinion in virology, 2(1)
Trivedi TK, Desai R, Hall AJ, Patel M, Parashar UD, Lopman BA. (2013). Clinical characteristics of norovirus-associated deaths: a systematic literature review. American journal of infection control, 41(7)
Trivedi TK, DeSalvo T, Lee L, Palumbo A, Moll M, Curns A, Hall AJ, Patel M, Parashar UD, Lopman BA. (2012). Hospitalizations and mortality associated with norovirus outbreaks in nursing homes, 2009-2010. JAMA, 308(16)
Pitzer VE, Atkins KE, de Blasio BF, Van Effelterre T, Atchison CJ, Harris JP, Shim E, Galvani AP, Edmunds WJ, Viboud C, Patel MM, Grenfell BT, Parashar UD, Lopman BA. (2012). Direct and indirect effects of rotavirus vaccination: comparing predictions from transmission dynamic models. PLoS One, 7(8)
Hall AJ, Curns AT, McDonald LC, Parashar UD, Lopman BA. (2012). The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 55(2)
Desai R, Hembree CD, Handel A, Matthews JE, Dickey BW, McDonald S, Hall AJ, Parashar UD, Leon JS, Lopman B. (2012). Severe outcomes are associated with genogroup 2 genotype 4 norovirus outbreaks: a systematic literature review. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 55(2)
Lopman BA, Pitzer VE, Sarkar R, Gladstone B, Patel M, Glasser J, Gambhir M, Atchison C, Grenfell BT, Edmunds WJ, Kang G, Parashar UD. (2012). Understanding reduced rotavirus vaccine efficacy in low socio-economic settings. PloS one, 7(8)
Lopman BA, Payne DC, Tate JE, Patel MM, Cortese MM, Parashar UD. (2012). Post-licensure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011. Current opinion in virology, 2(4)
Bartsch SM, Lopman BA, Hall AJ, Parashar UD, Lee BY. (2012). The potential economic value of a human norovirus vaccine for the United States. Vaccine, 30(49)
Lopman BA, Curns AT, Yen C, Parashar UD. (2011). Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. The Journal of infectious diseases, 204(7)
Lopman BA, Hall AJ, Curns AT, Parashar UD. (2011). Increasing rates of gastroenteritis hospital discharges in US adults and the contribution of norovirus, 1996-2007. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 52(4)
Pitzer VE, Viboud C, Lopman BA, Patel MM, Parashar UD, Grenfell BT. (2011). Influence of birth rates and transmission rates on the global seasonality of rotavirus incidence. Journal of the Royal Society, Interface, 8(64)
Pitzer VE, Patel MM, Lopman BA, Viboud C, Parashar UD, Grenfell BT. (2011). Modeling rotavirus strain dynamics in developed countries to understand the potential impact of vaccination on genotype distributions. Proceedings of the National Academy of Sciences of the United States of America, 108(48)
Lopman B. (2011). Air sickness: vomiting and environmental transmission of norovirus on aircraft. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 53(6)
Phillips G, Tam CC, Rodrigues LC, Lopman B. (2011). Risk factors for symptomatic and asymptomatic norovirus infection in the community. Epidemiology and infection, 139(11)
Patel MM, Tate J, Cortese M, Payne DC, Armstrong G, Parashar UD, Lopman B. (2010). The impact of indirect benefits of vaccination on postlicensure vaccine effectiveness estimates: A scenario analysis. Vaccine, 28(50)
Atchison C, Iturriza-Gomara M, Tam C, Lopman B. (2010). Spatiotemporal dynamics of rotavirus disease in Europe: can climate or demographic variability explain the patterns observed. The Pediatric infectious disease journal, 29(6)
Phillips G, Tam CC, Rodrigues LC, Lopman B. (2010). Prevalence and characteristics of asymptomatic norovirus infection in the community in England. Epidemiology and infection, 138(10)
Phillips G, Tam CC, Conti S, Rodrigues LC, Brown D, Iturriza-Gomara M, Gray J, Lopman B. (2010). Community incidence of norovirus-associated infectious intestinal disease in England: improved estimates using viral load for norovirus diagnosis. American journal of epidemiology, 171(9)
Lopman BA, Nyamukapa C, Hallett TB, Mushati P, Spark-du Preez N, Kurwa F, Wambe M, Gregson S. (2009). Role of widows in the heterosexual transmission of HIV in Manicaland, Zimbabwe, 1998-2003. Sexually transmitted infections, (85 Suppl 1)
Atchison CJ, Tam CC, Hajat S, van Pelt W, Cowden JM, Lopman BA. (2010). Temperature-dependent transmission of rotavirus in Great Britain and The Netherlands. Proceedings. Biological sciences, 277(1683)
Lopman B, Armstrong B, Atchison C, Gray JJ. (2009). Host, weather and virological factors drive norovirus epidemiology: time-series analysis of laboratory surveillance data in England and Wales. PLoS One, 4(8)
B Lopman, A Cook, J Smith, G Chawira, M Urassa, Y Kumogola, R Isingo, C Ihekweazu, J Ruwende, M Ndege, S Gregson, B Zaba, T Boerma. (2009). Verbal autopsy can consistently measure AIDS mortality: a validation study in Tanzania and Zimbabwe. BMJ Epidemiology & Community Health
Haustein T, Harris JP, Pebody R, Lopman BA. (2009). Hospital admissions due to norovirus in adult and elderly patients in England. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 49(12)
Lopman B, Zambon M, Brown DW. (2008). The evolution of norovirus, the "gastric flu". PLoS medicine, 5(2)
Harris JP, Edmunds WJ, Pebody R, Brown DW, Lopman BA. (2008). Deaths from norovirus among the elderly, England and Wales. Emerging infectious diseases, 14(10)
Lopman B, Nyamukapa C, Mushati P, Mupambireyi Z, Mason P, Garnett GP, Gregson S. (2008). HIV incidence in 3 years of follow-up of a Zimbabwe cohort--1998-2000 to 2001-03: contributions of proximate and underlying determinants to transmission. International journal of epidemiology, 37(1)
Lopman B, Gregson S. (2008). When did HIV incidence peak in Harare, Zimbabwe? Back-calculation from mortality statistics. PLoS One, 3(3)
Lopman B, Lewis J, Nyamukapa C, Mushati P, Chandiwana S, Gregson S. (2007). HIV incidence and poverty in Manicaland, Zimbabwe: is HIV becoming a disease of the poor?. AIDS (London, England), (21 Suppl 7)
Smith J, Mushati P, Kurwa F, Mason P, Gregson S, Lopman B. (2007). Changing patterns of adult mortality as the HIV epidemic matures in Manicaland, eastern Zimbabwe. AIDS (London, England), (21 Suppl 6)
Lopman BA, Barnabas RV, Boerma JT, Chawira G, Gaitskell K, Harrop T, Mason P, Donnelly CA, Garnett GP, Nyamukapa C, Gregson S. (2006). Creating and validating an algorithm to measure AIDS mortality in the adult population using verbal autopsy. PLoS medicine, 3(8)
Lopman BA, Barnabas R, Hallett TB, Nyamukapa C, Mundandi C, Mushati P, Garnett GP, Gregson S. (2006). Assessing adult mortality in HIV-1-afflicted Zimbabwe (1998 -2003). Bulletin of the World Health Organization, 84(3)
Lopman BA, Gallimore C, Gray JJ, Vipond IB, Andrews N, Sarangi J, Reacher MH, Brown DW. (2006). Linking healthcare associated norovirus outbreaks: a molecular epidemiologic method for investigating transmission. BMC infectious diseases, (6)
Lopman BA, French KM, Baggaley R, Gregson S, Garnett GP. (2006). HIV-contaminated syringes are not evidence of transmission. AIDS (London, England), 20(14)
Lopman B. (2006). Noroviruses: simple detection for complex epidemiology. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 42(7)
Lopman BA, Garnett GP, Mason PR, Gregson S. (2005). Individual level injection history: a lack of association with HIV incidence in rural Zimbabwe. PLoS medicine, 2(2)
Lopman BA, Reacher MH, Vipond IB, Sarangi J, Brown DW. (2004). Clinical manifestation of norovirus gastroenteritis in health care settings. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 39(3)
Lopman BA, Reacher MH, Vipond IB, Hill D, Perry C, Halladay T, Brown DW, Edmunds WJ, Sarangi J. (2004). Epidemiology and cost of nosocomial gastroenteritis, Avon, England, 2002-2003. Emerging infectious diseases, 10(10)
Lopman B, Vennema H, Kohli E, Pothier P, Sanchez A, Negredo A, Buesa J, Schreier E, Reacher M, Brown D, Gray J, Iturriza M, Gallimore C, Bottiger B, Hedlund KO, Torvén M, von Bonsdorff CH, Maunula L, Poljsak-Prijatelj M, Zimsek J, Reuter G, Szücs G, Melegh B, Svennson L, van Duijnhoven Y, Koopmans M. (2004). Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. Lancet, 363(9410)
Lopman BA. (2004). Emerging Themes in Epidemiology: Form and function. Emerging themes in epidemiology, 1(1)
Koopmans M, Vennema H, Heersma H, van Strien E, van Duynhoven Y, Brown D, Reacher M, Lopman B, . (2003). Early identification of common-source foodborne virus outbreaks in Europe. Emerging infectious diseases, 9(9)
Lopman BA, Tam CC. (2003). Epidemiologists: clinging to coat-tails or donning them?. International journal of epidemiology, 32(5)
Lopman BA, Reacher M, Gallimore C, Adak GK, Gray JJ, Brown DW. (2003). A summertime peak of "winter vomiting disease": surveillance of noroviruses in England and Wales, 1995 to 2002. BMC Public Health, (3)
Lopman BA, Reacher MH, Van Duijnhoven Y, Hanon FX, Brown D, Koopmans M. (2002). Viral gastroenteritis outbreaks in Europe, 1995-2000. Emerging infectious diseases, 9(1)
Lopman BA, Adak GK, Reacher MH, Brown DW. (2002). Two epidemiologic patterns of norovirus outbreaks: surveillance in England and wales, 1992-2000. Emerging infectious diseases, 9(1)
Lopman B, van Duynhoven Y, Hanon FX, Reacher M, Koopmans M, Brown D, . (2002). Laboratory capability in Europe for foodborne viruses. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 7(4)
Lopman BA, Brown DW, Koopmans M. (2002). Human caliciviruses in Europe. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 24(3)
Jones HC, Lopman BA. (1998). The relation between CSF pressure and ventricular dilatation in hydrocephalic HTx rats. European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie, (8 Suppl 1)
If you’d like to update your profile, please email modifications to questions@midasnetwork.us.